Hermab 150mg Injection

About

Hermab 150mg Injection is a targeted therapy, likely a monoclonal antibody, designed to treat certain types of cancer. It works by specifically binding to and blocking the activity of growth factor receptors, such as HER2, which are overexpressed on the surface of some cancer cells. This action inhibits cell proliferation, promotes apoptosis (programmed cell death), and reduces tumor growth. It is often used in combination with chemotherapy or other anti-cancer agents to enhance therapeutic outcomes.

This medication is crucial in managing HER2-positive malignancies, where it helps to improve progression-free survival and overall survival rates. Its targeted mechanism aims to minimize damage to healthy cells compared to conventional chemotherapy, offering a more precise approach to cancer treatment. Regular monitoring for potential side effects, especially cardiac function, is essential during therapy.

Uses

• Treatment of HER2-positive metastatic breast cancer.
• Adjuvant therapy for early-stage HER2-positive breast cancer.
• Management of HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma.
• Used in combination with other anti-cancer agents.

Directions For Use

Administered intravenously by a healthcare professional. Dosage and frequency are determined by the patient's condition and treatment protocol.

Benefits

• Targets specific cancer cells with HER2 overexpression.
• Significantly improves progression-free and overall survival.
• Effective in both early and metastatic stages of cancer.
• Can be combined with chemotherapy for enhanced efficacy.
• Offers a more precise treatment approach than traditional chemotherapy.
• Well-established clinical efficacy and safety profile.

Side Effects

• Infusion-related reactions (fever, chills, nausea).
• Cardiac dysfunction (e.g., decreased left ventricular ejection fraction).
• Diarrhea.
• Nausea and vomiting.
• Fatigue and asthenia.
• Headache.
• Rash.
• Abdominal pain.
• Anemia.
• Neutropenia.
• Peripheral edema.
• Myalgia.

Safety Measures

• Alcohol - Generally advised to limit or avoid alcohol due to potential for increased side effects or liver strain, especially during cancer treatment.
• Pregnancy - Contraindicated due to potential fetal harm; effective contraception is required during and for a period after treatment.
• Breastfeeding - Not recommended due to potential transfer into breast milk and harm to the infant.
• Liver - Use with caution in patients with pre-existing liver impairment; monitoring of liver function tests may be necessary.
• Kidney - Use with caution in patients with renal impairment; dosage adjustments may be required based on kidney function.
• Lung - Monitor for pulmonary toxicity, including interstitial lung disease; use with caution in patients with pre-existing lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.